• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于定量SUVN-502及其代谢物的灵敏液相色谱-串联质谱法的开发与验证及其在人体首次药代动力学研究中的应用

Development and validation of sensitive LC-MS/MS method for the quantification of SUVN-502 and its metabolite and its application for first in human pharmacokinetic study.

作者信息

Nirogi Ramakrishna, Ajjala Devender Reddy, Aleti Raghupathi, Rayapati Lakshmiprasanna, Pantangi Hanumanth Rao, Boggavarapu Rajesh Kumar, Padala Naga Surya Prakash

机构信息

Biopharmaceutical Research, Suven Life Sciences Ltd., Serene Chambers, Road - 5, Avenue - 7, Banjara Hills, Hyderabad 500034, India.

Biopharmaceutical Research, Suven Life Sciences Ltd., Serene Chambers, Road - 5, Avenue - 7, Banjara Hills, Hyderabad 500034, India.

出版信息

J Pharm Biomed Anal. 2017 Oct 25;145:423-430. doi: 10.1016/j.jpba.2017.04.005. Epub 2017 Apr 14.

DOI:10.1016/j.jpba.2017.04.005
PMID:28734271
Abstract

A sensitive and rapid LC-MS/MS method was developed and validated for the quantification of SUVN-502 and M1 of SUVN-502, a 5-HT receptor antagonist for the treatment of dementia associated with Alzheimer's disease. Following solid-phase extraction, SUVN-502 and M1 of SUVN-502 and IS were eluted with 10mM ammonium acetate (pH 4.0) and acetonitrile using a rapid gradient program on reverse phase column. Multiple reaction monitoring mode was used to monitor the respective transitions of m/z 478.2→377.7 for SUVN-502 and m/z 464.1→377.7 for M1 of SUVN-502. The assay exhibited a linear dynamic range of 10-10000pg/mL for SUVN-502 and 20-20000pg/mL for M1 of SUVN-502 in human plasma. Acceptable precision and accuracy were obtained for concentrations over the standard curve range. The within batch accuracy and precision were within acceptable limits. All the other validation parameters were within the acceptable limits. The validated method was applied to analyze human plasma samples obtained from a human pharmacokinetic study consisting single and multiple ascending doses.

摘要

开发并验证了一种灵敏、快速的液相色谱-串联质谱法,用于定量测定SUVN-502及其代谢物M1,SUVN-502是一种用于治疗阿尔茨海默病相关痴呆的5-羟色胺受体拮抗剂。在固相萃取后,使用反相柱上的快速梯度程序,用10mM醋酸铵(pH 4.0)和乙腈洗脱SUVN-502及其代谢物M1和内标。采用多反应监测模式监测SUVN-502的m/z 478.2→377.7和SUVN-502代谢物M1的m/z 464.1→377.7的各自跃迁。该测定法在人血浆中对SUVN-502的线性动态范围为10-10000pg/mL,对SUVN-502代谢物M1的线性动态范围为

相似文献

1
Development and validation of sensitive LC-MS/MS method for the quantification of SUVN-502 and its metabolite and its application for first in human pharmacokinetic study.用于定量SUVN-502及其代谢物的灵敏液相色谱-串联质谱法的开发与验证及其在人体首次药代动力学研究中的应用
J Pharm Biomed Anal. 2017 Oct 25;145:423-430. doi: 10.1016/j.jpba.2017.04.005. Epub 2017 Apr 14.
2
A selective and accurate liquid chromatography-tandem mass spectrometry method for the quantitation of the novel 5-HT receptor partial agonist SUVN-D4010 (Usmarapride) in human plasma and urine.一种选择性和准确的液相色谱-串联质谱法,用于定量人血浆和尿液中新的 5-HT 受体部分激动剂 SUVN-D4010(Usmarapride)。
J Pharm Biomed Anal. 2022 Mar 20;211:114617. doi: 10.1016/j.jpba.2022.114617. Epub 2022 Jan 29.
3
LC-MS/MS method for the quantification of aldose reductase inhibitor-epalrestat and application to pharmacokinetic study.LC-MS/MS 法测定醛糖还原酶抑制剂依帕司他及其在药代动力学研究中的应用。
J Pharm Biomed Anal. 2013 Feb 23;74:227-34. doi: 10.1016/j.jpba.2012.10.020. Epub 2012 Oct 23.
4
Analysis of prasugrel active metabolite R-138727 in human plasma: a sensitive, highly selective and fast LC-MS/MS method.
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 May 1;1020:103-10. doi: 10.1016/j.jchromb.2016.03.035. Epub 2016 Mar 24.
5
Safety, Tolerability and Pharmacokinetics of the Serotonin 5-HT6 Receptor Antagonist, SUVN-502, in Healthy Young Adults and Elderly Subjects.健康年轻成年受试者和老年受试者中 5-羟色胺 5-HT6 受体拮抗剂 SUVN-502 的安全性、耐受性和药代动力学。
Clin Drug Investig. 2018 May;38(5):401-415. doi: 10.1007/s40261-018-0618-4.
6
Quantification of urapidil, α-1-adrenoreceptor antagonist, in plasma by LC-MS/MS: validation and application to pharmacokinetic studies.采用液相色谱-串联质谱法对血浆中α-1肾上腺素能受体拮抗剂乌拉地尔进行定量分析:方法验证及其在药代动力学研究中的应用。
Biomed Chromatogr. 2011 Dec;25(12):1319-26. doi: 10.1002/bmc.1604. Epub 2011 Feb 10.
7
Quantification of trandolapril and its metabolite trandolaprilat in human plasma by liquid chromatography/tandem mass spectrometry using solid-phase extraction.采用固相萃取-液相色谱/串联质谱法测定人血浆中群多普利及其代谢产物群多普利拉的含量。
Rapid Commun Mass Spectrom. 2006;20(24):3709-16. doi: 10.1002/rcm.2794.
8
Determination of silodosin in human plasma by liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法测定人血浆中的西洛多辛。
J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Nov 1;877(29):3724-8. doi: 10.1016/j.jchromb.2009.08.025. Epub 2009 Aug 21.
9
Development and validation of a liquid chromatography-tandem mass spectrometry method for the assay of tafamidis in rat plasma: Application to a pharmacokinetic study in rats.液相色谱-串联质谱法测定大鼠血浆中他氟米特的方法开发与验证:在大鼠药代动力学研究中的应用
J Pharm Biomed Anal. 2017 Apr 15;137:90-95. doi: 10.1016/j.jpba.2017.01.020. Epub 2017 Jan 10.
10
Highly sensitive LC-MS/MS-ESI method for determination of phenelzine in human plasma and its application to a human pharmacokinetic study.用于测定人血浆中苯乙肼的高灵敏度液相色谱-串联质谱-电喷雾电离方法及其在人体药代动力学研究中的应用。
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Jun 1;1022:126-132. doi: 10.1016/j.jchromb.2016.04.006. Epub 2016 Apr 9.

引用本文的文献

1
G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits.中枢神经系统中的 G 蛋白偶联受体:干预神经退行性疾病和相关认知缺陷的潜在治疗靶点。
Cells. 2020 Feb 23;9(2):506. doi: 10.3390/cells9020506.
2
5HT6 Antagonists in the Treatment of Alzheimer's Dementia: Current Progress.5-羟色胺6拮抗剂在阿尔茨海默病性痴呆治疗中的研究进展
Neurol Ther. 2018 Jun;7(1):51-58. doi: 10.1007/s40120-018-0095-y. Epub 2018 May 2.
3
Safety, Tolerability and Pharmacokinetics of the Serotonin 5-HT6 Receptor Antagonist, SUVN-502, in Healthy Young Adults and Elderly Subjects.
健康年轻成年受试者和老年受试者中 5-羟色胺 5-HT6 受体拮抗剂 SUVN-502 的安全性、耐受性和药代动力学。
Clin Drug Investig. 2018 May;38(5):401-415. doi: 10.1007/s40261-018-0618-4.